465 filings
S-3ASR
MRSN
Mersana Therapeutics Inc
9 May 23
Automatic shelf registration
4:10pm
10-Q
2023 Q1
MRSN
Mersana Therapeutics Inc
Quarterly report
9 May 23
8:55am
8-K
MRSN
Mersana Therapeutics Inc
9 May 23
Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results
7:11am
4
Carvajal Alejandra
28 Apr 23
Mersana Therapeutics / Alejandra Carvajal ownership change
4:15pm
ARS
2022 FY
MRSN
Mersana Therapeutics Inc
28 Apr 23
Annual report to shareholders
6:04am
DEFA14A
MRSN
Mersana Therapeutics Inc
28 Apr 23
Additional proxy soliciting materials
6:02am
DEF 14A
MRSN
Mersana Therapeutics Inc
Definitive proxy
28 Apr 23
6:00am
PRE 14A
MRSN
Mersana Therapeutics Inc
Preliminary proxy
14 Apr 23
4:11pm
4
MRSN
Mersana Therapeutics Inc
5 Apr 23
Mersana Therapeutics / Kristen Hege ownership change
5:15pm
4
Huber Martin H. Jr.
5 Apr 23
Mersana Therapeutics / Martin H. Jr. Huber ownership change
5:15pm
4
Mott David M
5 Apr 23
Mersana Therapeutics / DAVID M MOTT ownership change
5:14pm
4
Alleva Lawrence M
5 Apr 23
Mersana Therapeutics / Lawrence M Alleva ownership change
5:14pm
4
MRSN
Mersana Therapeutics Inc
5 Apr 23
Mersana Therapeutics / Willard H Dere ownership change
5:12pm
8-K
MRSN
Mersana Therapeutics Inc
31 Mar 23
Amendments to Articles of Incorporation or Bylaws
4:11pm
8-K
MRSN
Mersana Therapeutics Inc
24 Mar 23
Entry into a Material Definitive Agreement
4:12pm
8-K
MRSN
Mersana Therapeutics Inc
13 Mar 23
Mersana Therapeutics Provides Statement About SVB
8:01am
S-8
MRSN
Mersana Therapeutics Inc
28 Feb 23
Registration of securities for employees
4:37pm
10-K
2022 FY
MRSN
Mersana Therapeutics Inc
Annual report
28 Feb 23
8:37am
8-K
MRSN
Mersana Therapeutics Inc
28 Feb 23
Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2022 Financial Results
7:17am
SC 13G
MRSN
Mersana Therapeutics Inc
14 Feb 23
Mersana Therapeutics / ORBIMED ADVISORS ownership change
4:43pm